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Abstract
Purpose Rats are widely used in biomedical research involv-
ing molecular imaging and therefore the radiation dose to
animals has become a concern. The weight of laboratory
animals might change through emaciation or obesity as a
result of their use in various research experiments including
those investigating different diet types. In this work, we eval-
uated the effects of changes in body weight induced by
emaciation and obesity on the internal radiation dose from
common positron-emitting radionuclides.
Methods A systematic literature review was performed to
determine normal anatomical parameters for adult rats and
evaluate how organs change with variations in total body
weight. The ROBY rat anatomical model was then modified
to produce a normal adult rat, and mildly, moderately and
severely emaciated and obese rats. Monte Carlo simulations
were performed using MCNPX to estimate absorbed frac-
tions, specific absorbed fractions (SAFs) and S-values for
these models using different positron-emitting radionuclides.
The results obtained for the different models were compared
to corresponding estimates from the normal rat model.
Results The SAFs and S-values for most source–target pairs
between the various anatomical models were not significantly
different, except where the intestine and the total body were
considered as source regions. For the intestine, irradiating
other organs in the obese model, the SAFs in organs in the
anterior region of the splanchnocoele (e.g. kidney, liver and
stomach) increased slightly, whereas the SAFs in organs in the
posterior region of the splanchnocoele (e.g. bladder and testes)
decreased owing to the increase in the distance separating the
intestine and posterior abdominal organs because of the rat
epididymal fat pad. For the total body, irradiating other or-
gans, the SAFs and S-values were inversely related to body
weight.
Conclusion The effect of obesity on internal radiation dose is
insignificant in most conditions for common positron-emitting
radionuclides. Emaciation increases the cross-absorbed dose to
organs from surrounding tissues, which might be a notable
issue in laboratory animal internal dosimetry.
Keywords Radiation dosimetry . Small animals . PET .
Monte Carlo . Computational models
Introduction
The role of transgenic and knockout mice has become pro-
found and widespread in biomedical research. Nowadays,
transgenic laboratory animals can be designed and created in
a way that offers attractive possibilities for addressing basic
research questions concerning the genetic, molecular and
cellular basis of biology and disease. Rats are widely used
as models of human disease in preclinical trials for the
development of new molecular imaging probes, drug discov-
ery, gene expression, development of therapeutic targets,
targeted therapies and many other research applications
[1, 2]. With the ever increasing number and importance
of human disease models in rodents, the potential of high-
resolution preclinical PET instrumentation to contribute
unique information has become evident. In this context, the
accurate assessment of radiation dose delivered to laboratory
animals in experiments involving the use of multimodality
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molecular imaging instruments including SPECT, PET and
CT is of paramount importance.
For this purpose, various computational rat models have
been used extensively as input to Monte Carlo-based radia-
tion transport packages to achieve this goal. To this end,
three types of computational models have emerged: (1) styl-
ized models, (2) voxel-based models, and (3) hybrid equa-
tion–voxel-based models [3]. Stylized models use simple
equation-based mathematical functions (surface equations)
to represent internal organs and external boundaries of the
defined model, thus minimizing computational time. Voxel-
based models employ voxel matrices derived from segment-
ed tomographic images for the best anatomical authenticity.
The recently introduced hybrid equation–voxel approach
combines the first two approaches by allowing the mathe-
matical description of organ boundaries from definitions
extracted from voxel data [4].
Hui et al. [5] developed the first stylized mouse model for
radiation dose calculation. Further improvements led to finer
stylized small-animal models including rat [6, 7] and mouse
models containing more internal organs and even realistic
tumour models [8–10]. Likewise, various voxel-based small-
animal models have been developed by different groups for
radiation dosimetry research using different specimens
[11–19]. More recently, computational models of laboratory
animals based on non-uniform rational B-spline surfaces
(NURBS) have become available [20]. These models repre-
sent surface contours of organs and tissues, and thus retain
most anatomical characteristics and offer the flexibility of
deforming these structures more realistically. They are be-
coming more and more popular and are now considered
standard for Monte Carlo-based radiation transport calcula-
tions [21, 22]. However, there is an intrinsic variability in the
total body weight of rats because of differences between
specimens. Moreover, in some preclinical research studies,
the weight of laboratory animals used in longitudinal studies
can be modified by emaciation or obesity because of sec-
ondary effects of drugs, radiation therapy or chemotherapy
and the use of dietary or fat regimes [23–28]. In adult rats
older than 250–300 days, the increase in weight, referred to
as adult ‘growth’ [29], has been reported to be due mostly to
fat deposition. Therefore, the assessment of the impact of
changes in body weight due to emaciation and obesity on
internal radiation dose from common radionuclides used in
molecular imaging is highly desired and has not been report-
ed before in the scientific literature.
In this work, the model used for reference dose estimation
was based on the growth chart and reported weight and length
values of 11-week old normal adult male rats [30]. We
constructed a series of models representingmildly, moderately
and severely emaciated and obese rats of the same age, and
compared the resulting specific absorbed fractions (SAFs) and
S-values for common positron-emitting radionuclides with
those in the normal rat model. The assessment of the variabil-
ity in absorbed dose estimates with emaciation and obesity is
important to understand the uncertainties involved in internal
radiation dose calculations for small animals.
Materials and methods
Design of computational rat models
The normal rat model was constructed from the realistic four-
dimensional digital rat whole-body (ROBY) model [20]
according to the reported weight and length values for 11-week
old normal adult male rats (Fig. 1d) [30]. The weight/length ratio
is used to determine whether a given rat is emaciated or obese
[30]. The weight/length ratio of 11-week-old normal adult male
rats (NWLR11) was set as the reference in this work. Similar to
the concept of body mass index used in human health-care
standards [31, 32], we divided rats at the same age (11 weeks)
into seven different categories according to the percentage
weight/length ratio in relation to the NWLR11 (%NWLR11):
severely emaciated (≤75 %NWLR11), moderately emaciated
(76–85%NWLR11), mildly emaciated (86–95%NWLR11), nor-
mal (96–119 %NWLR11), mildly obese (120–129 %NWLR11),
moderately obese (130–149 %NWLR11) and severely obese
(≥150 %NWLR11). The lengths of the rat models were kept at
a preset value (23.7 cm)while the body contour of the rat models
was adjusted locally and scaled to reflect the different propor-
tions of emaciation or obesity. Emaciation of rats is usually
observed as extensive fatty tissue wasting, and atrophy of the
muscles and some internal organs [24, 33, 34]. Since different
radiotracers result in different biodistributions and as such vari-
ous degrees of secondary effects in different internal organs, it is
hard to systematically consider the atrophy of all organs in the
modelling. Therefore, in the emaciated rat models, we only
considered the decrease in subcutaneous fat, loss of adipose
tissue in the visceral fat pad, and slight muscle atrophy. The
adipose tissue was integrated with muscle and other unlabelled
organs into other tissues of normal and emaciated models. In
the obese rat models, since the adipose tissue consists
mainly of subcutaneous fat and visceral fat (including epi-
didymal fat, mesenteric fat, omental fat and perinephric fat)
[35, 36], the body contour was scaled to mimic the increase in
subcutaneous fat and an ellipsoidal visceral adipose tissue area
was defined and used to expand the intestines into the
ventrodorsal and lateral dimensions from the normal rat mod-
el. In the male rat body, a large percentage (>20 %) of adipose
tissue is stored in the epididymal fat pad [35] and the intestine
folds are pressed in the cephalic direction because of an
increase in the volume of epididymal fat pad behind them.
Figures 1 and 2 show three-dimensional ventral views and
transverse cross sections, respectively, of the normal, emaci-
ated and obese rat models.
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Monte Carlo simulations
The scaled NURBS-based rat models were voxelized using the
ROBY software [20] and used as input to the MCNPXMonte
Carlo code [37] to simulate the transport and interaction of
photons and electrons in the computational rat models. The
number of voxels of each identified region was calculated and
multiplied by the voxel volume (0.5×0.5×0.5 mm) and corre-
sponding tissue density to yield the region mass. The density
and chemical composition of each organ were assumed similar
to those in humans [38, 39]. Monoenergetic photons and
electrons were generated from most body organs with 20
discrete photon energies ranging from 0.01 to 3.0 MeV and
13 selected electron energies ranging from 0.1 to 3.0 MeV. A
total of 6×106 primary particle histories were generated
resulting in a statistical uncertainty, in terms of coefficient of
variation, of less than 2 % in most cases. The absorbed frac-
tions, reflecting the proportion of energy released in source
organs and deposited in the target organ, were calculated for all
organs. These estimates were then compared with similar
quantities calculated for the seven developed rat models as
well as computational rat models developed by Stabin et al.
[11], Peixoto et al. [17] and Xie et al. [7, 40]. In addition, the
SAFs, reflecting the mean absorbed fraction in a target organ,
were also calculated based on the absorbed fractions. Photon
and electron SAFs for selected body regions in emaciated,
obese and normal rat models were then analysed.
We also simulated uniformly distributed positron-emitting
radionuclides in 14 chosen source regions of the generat-
ed emaciated, obese and normal rat models. The select-
ed radionuclides included 11C, 13N, 15O, 18F, 64Cu, 68Ga, 86Y
and 124I, which are commonly used to label various probes in
small-animal PET imaging [41–43]. The Medical Internal
Fig. 1 Three-dimensional ventral views of the mild, moderate and
severely emaciated and obese rat models with semitransparent skin in
comparison to the normal-weight rat model. The dash lines (red) are the
positions of the cross sections shown in Fig. 2
Fig. 2 Cross sections of
computational rat models
demonstrating mild, moderate
and severe emaciation and
obesity in comparison to the
normal-weight rat model
1750 Eur J Nucl Med Mol Imaging (2013) 40:1748–1759
Radionuclide Dose Committee (MIRD) schema [44] was
employed to assess S-values of the considered radionuclides
obtained by multiplying the energy and average number of
particles per nuclear disintegration and the absorbed fraction
for a given source–target combination divided by the mass of
the target region [44, 45]. The decay data of these positron-
emitting radionuclides were obtained from the Health Physics
Society electronic resource [46]. The percentage differences in
S-values of several organ pairs for 18F were estimated for
emaciated and obese models with respect to the normal rat
model and are expressed as the percentage differences per 10 g
difference in the model’s total body mass.
Results
Rat models
Table 1 summarizes the masses of organs/tissues of the gen-
erated normal, emaciated and obese computational rat models.
The %NWLR11 of the normal rat model was 100 % while the
%NWLR11 for the severely, moderately and mildly emaciated
rat models were 75 %, 85 % and 95 %, respectively. The
%NWLR11 for the severely, moderately and mildly obese rat
models were 120 %, 140 % and 167 %, respectively. The
masses of internal organs in the emaciated and obese rat
models were quite similar to those in the normal rat model.
In the obese rat models, some organs in the splanchnocoele
were surrounded by layers of fat tissue, whereas other organs,
such as the intestine, were slightly deformed and displaced.
Absorbed fractions and specific absorbed fractions
Figure 3 shows photon self-absorbed fractions for the liver
and the heart of the seven generated rat models. Comparisons
with the results of Stabin et al. [11], Peixoto et al. [17] and Xie
et al. [7] are also given. Consistent tendencies of curves are
presented and self-absorbed fractions of different rat models
are close together. Figures 4 and 5 show photon and electron
SAFs for the stomach self-irradiation, the stomach and kid-
neys, and the intestine irradiating the stomach and the bladder,
respectively. The relative SAF differences for most source–
target pairs between the emaciated models and the reference
model and between the obese models and the reference model
were lower than 1 %. However, for obese rats, the SAFs for
the intestine irradiating the anterior abdominal organs (e.g.
stomach, kidney, spleen) were higher, whereas the SAFs for
the intestine irradiating the posterior abdominal organs (e.g.
bladder, testis) were lower than those in the normal model. As
can be seen in Fig. 5a, photon SAFs for the intestines irradi-
ating the stomach were about 5 % higher in the mildly obese
model, 10 % higher in the moderately obese model and 12 %
higher in the severely obese model. On the other hand, the
electron SAFs for the intestines irradiating the stomach were
about 5 % higher in the mildly obese model, 23 % higher in
the moderately obese model and 35 % higher in the severely
Table 1 Organ masses (in grams)
in the various computational rat
models
Organ Severe
emaciation
Moderate
emaciation
Mild
emaciation
Normal Mild
obesity
Moderate
obesity
Severe
obesity
Skeleton 34.34 34.30 34.32 34.32 34.31 34.35 34.35
Heart 2.46 2.47 2.46 2.46 2.46 2.46 2.46
Lung 1.20 1.20 1.20 1.20 1.20 1.19 1.19
Liver 11.75 11.76 11.75 11.75 11.75 11.75 11.75
Stomach 5.10 5.10 5.11 5.10 5.10 5.10 5.10
Kidney 3.14 3.15 3.15 3.15 3.15 3.15 3.15
Intestine 27.21 27.22 27.21 27.21 27.21 27.20 27.21
Spleen 0.90 0.90 0.90 0.90 0.90 0.90 0.90
Bladder 0.69 0.69 0.69 0.69 0.69 0.69 0.69
Testis 0.18 0.18 0.18 0.18 0.18 0.18 0.18
Skin 17.41 17.83 18.61 19.00 20.41 21.68 23.50
Brain 5.52 5.52 5.52 5.52 5.52 5.52 5.52
Thyroid 0.29 0.29 0.29 0.29 0.29 0.29 0.29
Pancreas 0.56 0.56 0.56 0.56 0.56 0.56 0.56
Vas deferens 0.06 0.06 0.06 0.06 0.06 0.06 0.06
Fat pad – – – – 27.54 41.94 47.60
Other tissues 160.66 195.68 231.41 248.42 288.39 343.11 432.52
Total 271.47 306.90 343.42 360.80 429.73 500.13 597.03
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obese model in relation to the reference model. For the intes-
tine and bladder, the photon SAFs were 4 %, 24 % and 35 %
and the electron SAFs were 31%, 48% and 63% lower in the
mildly, moderately and severely obese models, respectively, in
relation to those in the normal model.
SAFs for cross-irradiation of the total body
In human dose calculations, cross-absorbed SAFs for organs
are commonly negligible [45] since the range of low-energy
electrons is smaller than the dimensions ofmost human organs
Fig. 4 Photon SAFs (a, c) and electron SAFs (b, d) for the stomach self-irradiation (a, b) and the stomach irradiating the kidneys (c, d)
Fig. 3 Photon self-absorbed fractions for the liver (a) and the heart (b) in the various rat models used in this work. The results of Stabin et al. [11],
Peixoto et al. [17] and Xie et al. [7] are also shown
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[47]. However, given that the body dimensions of rats are
much smaller, it is necessary to evaluate the cross-absorbed
SAFs in rat internal radiation dosimetry. Figure 6 shows
photon and electron SAFs for the total body, skeleton and
heart, with the total body being the source organ. Overall, for
the same photon or electron energy, the obese models have
higher SAF for the total body irradiating itself and other
organs. This indicates that the SAF of the total body is
positively correlated with the mass of the rat. Figure 7 shows
photon and electron SAF ratios of the various rat models
(from severely emaciated to severely obese) to the normal
rat model for the total body irradiating the skeleton. At an
emitting photon energy of 10 keV, the maximum percentage
differences in photon SAFs for the total body irradiating the
skeleton between the mildly, moderately and severely emaci-
ated models and the normal model were 7 %, 25 % and 48 %,
respectively, while the differences between the mildly, mod-
erately and severely obese models and the normal model
were −12 %, −27 %, and −41 %, respectively. When photon
energy increased, the absolute differences in photon SAFs
between the emaciated and obese models and the normal
model initially showed a rapid decrease followed by a slight
increase before reaching a plateau in the energy range 0.4–
2.0 MeV. For electron SAFs for the total body irradiating the
skeleton, the absolute differences between the emaciated
models and the normal model showed a slight decrease with
an increase in electron energy.
S-values for positron-emitters
Figure 8 shows S-value ratios for 11C, 124I, 18F and 86Y
positron-emitting radionuclides for different source–target or-
gan pairs between the six rat models and the normal rat model.
Similar to the previous SAF results, the S-values for the total
body irradiating other organs decreased with increasing body
mass. From the severely emaciated model to the normal
model, the self-absorbed S-values were generally constant.
From the normal to the severely obese model, S-values for
the intestine irradiating the anterior abdominal organs in-
creased but decreased for the posterior abdominal organs.
Figure 9 shows S-value ratios between the seven rat models
and the normal rat model for the total body irradiating the total
Fig. 5 Photon SAFs (a, c) and electron SAFs (b, d) for the intestine irradiating the stomach (a, b) and the intestine irradiating the bladder (c, d)
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body and skeleton for the eight positron-emitting radionu-
clides (11C, 13N, 15O, 18F, 64Cu, 68Ga, 86Y and 124I). For all
positron-emitting radionuclides, the S-values decreased with
increasing body mass. The rate of decrease in S-values was
higher from the severely emaciated model to the normal
model than from the normal model to the severely obese
model. The percentage differences in S-values per 10 g dif-
ference in total body mass (%/10 g) for 18F are presented in
Fig. 6 Photon SAFs (a, c, e) and electron SAFs (b, d, f) for the total body irradiating the total body (a, b), the total body irradiating the skeleton (c, d)
and the total body irradiating the heart (e, f)
1754 Eur J Nucl Med Mol Imaging (2013) 40:1748–1759
Fig. 7 Photon SAF ratios (a) and electron SAF ratios (b) for the total body irradiating the skeleton
Fig. 8 Ratios of S-values for different source–target organ pairs for 11C (a), 124I (b), 18F (c) and 86Y (d). The corresponding values from the normal
rat model are taken as the reference values
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Table 2 between the severely emaciated model and the normal
model and in Table 3 between the severely obese model and
the normal model.
Discussion
Recent advances in the development of sophisticated deform-
able computational anatomical models of laboratory animals
have stimulated and further encouraged the use ofMonte Carlo
techniques for radiation dosimetry calculations [3]. Current
developments are aimed at computational models that are
flexible while providing accurate modelling of various animal
species. To perform accurate animal-specific radiation dose
calculations, an animal-specific anatomical model to be used
with animal-specific biokinetic data is necessary. Individual
laboratory animals not only have significantly different tracer
uptake levels and retention half-lives of activity of the labelled
compound, but also have significantly different physical char-
acteristics and radiosensitivities. To optimize the design of
Fig. 9 Ratios of S-values for the total body irradiating the total body and the skeleton for 11C, 13N, 15O, 18F, 64Cu, 68Ga, 86Y and 124I. The
corresponding values from the normal rat model are taken as the reference values
Table 2 Percentage differences in S-values per 10 g difference (%/10 g) in total body mass for 18F between the severe emaciated model and the
normal model
Organ Skeleton Heart Lung Liver Stomach Kidney Intestine Spleen Bladder Testis Brain Thyroid Pancreas Total body
Skeleton −0.01 −0.05 −0.06 −0.09 −0.09 −0.19 −0.13 −0.05 −0.19 0.06 −0.05 −0.03 −0.04 2.99
Heart 0.03 −0.01 0.02 −0.05 0.02 0.02 0.23 0.16 −1.02 −1.58 0.35 0.07 0.45 2.81
Lung −0.03 0.09 0.04 −0.10 −0.21 0.06 −0.13 0.14 1.52 1.70 −0.14 −0.13 0.16 3.32
Liver 0.02 −0.05 0.00 0.00 −0.03 −0.05 −0.05 −0.11 −0.20 0.23 −0.23 −0.25 0.02 1.98
Stomach −0.29 −0.03 −0.07 0.03 −0.01 0.05 −0.11 0.03 −0.31 −0.06 −0.35 −0.26 −0.05 1.55
Kidney −0.18 −0.44 −0.04 −0.06 −0.16 0.00 0.14 −0.16 −0.27 −0.23 −0.89 −0.24 −0.10 2.10
Intestine −0.08 0.08 −0.21 −0.07 −0.03 −0.01 −0.01 −0.07 0.00 −0.39 −0.31 −0.35 0.02 2.03
Spleen 0.01 0.06 −0.11 −0.12 −0.06 0.12 −0.15 0.01 0.18 −0.36 −0.92 0.18 −0.25 1.97
Bladder −0.02 −0.21 −0.80 −0.61 0.47 −0.41 0.09 −1.20 −0.01 −0.06 −0.04 −0.10 −0.37 2.72
Testis 0.86 7.23 −0.95 0.53 −0.86 0.67 0.62 0.27 0.42 0.08 0.19 3.15 −1.06 2.50
Skin 2.23 1.70 2.06 1.60 1.77 2.52 2.18 2.42 3.11 3.34 1.19 1.48 2.02 4.47
Brain −0.04 0.01 −0.11 −0.36 −0.22 −0.45 −0.23 −0.41 −0.33 0.45 0.00 0.07 −0.59 2.40
Thyroid 0.48 −0.20 0.11 −0.29 0.95 −0.89 1.51 −0.05 −2.22 0.86 −0.15 −0.07 −0.74 3.76
Pancreas −0.03 −0.22 −0.08 −0.22 0.17 −0.07 −0.02 −0.04 −0.63 −0.35 −0.88 0.33 0.00 2.83
Total body 3.09 3.18 3.09 3.15 3.09 2.94 3.05 2.96 2.93 2.82 3.36 3.29 3.09 3.13
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experiments through accurate monitoring of radiation dose
delivered to animals, individual animal-related parameters
should be accounted for as much as possible.
The results obtained showed small variations in SAFs for
most source–target pairs between the emaciated, obese and
normal rat models. The SAFs from the intestine for the ante-
rior abdominal organs (e.g. stomach, kidney, spleen) and
posterior abdominal organs (e.g. bladder, testis) in the obese
model were, respectively, higher and lower than those in the
normal model because the increased volume of the epididymal
fat pad and visceral adipose tissues increased the separation
between the intestinal folds and the posterior abdominal or-
gans and reduced the distance from the folds to the anterior
abdominal organs. Because of the larger source–target sepa-
rations, the SAFs for the total body irradiating other regions
decreased with increasing body mass, and more significant
changes were more apparent at low photon energies.
Changes in S-values with emaciation and obesity were also
evaluated for eight positron-emitting radionuclides relevant for
research involving PET molecular imaging. Except for the
intestine and the total body, there was little difference between
S-values for most source–target pairs in the emaciated, obese
and normal rat models. In the obese rat models, the variations in
S-values of the intestine irradiating other organs were similar to
those for the photon and electron SAFs. S-values for the total
body were inversely correlated with body weight. The differ-
ences in S-values between the normal and the severely emaci-
ated models for the total body irradiating the skeleton varied
from 30 % to 50 % for the eight positron-emitting radionu-
clides. These results suggest that, in small-animal dosimetry,
body weight loss caused by the secondary effects of drugs and
other issues related to particular experiments will increase the
absorbed radiation dose to internal organs. In addition, the
radiation-induced organ damagemay aggravate the emaciation,
which would finally result in a vicious circle. The assessment
of internal radiation dose delivered to small animals in exper-
imental research is important for evaluations of radiotoxicity
and therapeutic effect of molecular imaging probes and thera-
peutic agents. In this regard, quantification of variations in
organ S-values with changes in total body mass caused by
emaciation or obesity is an important issue. Considering 18F
as an example, the absolute difference in S-values for organ
self-irradiation was lower than 0.05 % per 10 g of difference in
body weight. For organs irradiating other organs, most differ-
ences in cross-absorbed S-values were lower than 1 % per 10 g
and would not be perceptible within the uncertainties associat-
ed with dose calculations. However, S-value changes for the
total body were more noticeable, ranging between 1.5 % and
4.5 % per 10 g in emaciated models, and between −1.6 % and
−0.7 % per 10 g in obese models. Overall, changes in SAFs
and S-values induced by emaciation or obesity for most or-
gans may be neglected in small-animal internal dose esti-
mates. However, since the cross-absorbed radiation dose plays
a more important role in small animals than in humans [5, 7],
emaciation-induced increase in S-values for the total body
irradiating other organs is an important issue to consider in
small-animal radiation dosimetry calculations.
Conclusion
This work focused on the evaluation of the impact of ema-
ciation and obesity on small-animal internal radiation dosim-
etry. We constructed a realistic normal adult male rat model
Table 3 Percentage differences in S-values per 10 g difference (%/10 g) in total bodymass for 18F between the severe obesity model and the normal model
Organ Skeleton Heart Lung Liver Stomach Kidney Intestine Spleen Bladder Testis Brain Thyroid Pancreas Total body
Skeleton 0.00 0.04 −0.01 0.06 0.08 0.10 −0.06 0.13 0.05 0.05 0.02 0.06 0.08 −1.13
Heart 0.07 0.00 0.04 0.04 0.06 0.15 0.37 0.13 0.51 1.22 0.20 0.08 0.12 −0.87
Lung −0.03 0.05 0.03 0.02 −0.01 −0.05 0.41 −0.03 0.64 0.72 0.14 0.05 0.11 −1.07
Liver 0.06 0.03 0.02 0.00 0.02 0.01 0.57 0.04 0.17 0.32 0.20 0.13 0.04 −0.76
Stomach 0.10 0.00 0.04 0.02 0.00 0.01 0.46 0.01 0.21 0.18 0.21 0.23 0.00 −0.95
Kidney 0.12 0.12 0.12 0.01 0.07 0.00 0.30 0.06 0.04 0.18 0.32 0.29 0.04 −1.72
Intestine −0.08 0.46 0.41 0.53 0.52 0.26 −0.01 1.72 −1.62 −0.99 0.68 0.82 0.25 −1.84
Spleen 0.18 0.11 0.07 −0.01 0.00 0.06 1.88 0.00 0.17 0.14 0.46 0.23 0.02 −1.51
Bladder −0.02 0.28 0.40 0.20 0.25 0.07 −1.68 0.00 0.00 0.15 0.73 0.73 0.09 −2.66
Testis −0.09 1.84 −0.44 0.27 −0.38 0.50 −0.73 0.70 0.18 −0.01 1.08 1.65 0.03 −2.84
Skin −1.69 −1.54 −1.41 −1.52 −1.54 −1.30 −1.43 −1.44 −1.16 −1.71 −1.24 −1.52 −1.24 −1.43
Brain 0.01 0.14 0.14 0.37 0.20 0.35 0.24 0.37 0.33 0.54 0.00 0.08 0.03 −0.09
Thyroid 0.13 0.22 0.04 0.34 0.34 0.41 3.40 0.95 0.63 1.32 0.04 0.00 0.67 −0.71
Pancreas 0.03 0.05 −0.10 0.03 0.00 0.02 0.17 0.03 0.38 0.42 0.34 0.22 0.00 −1.85
Total body −1.47 −1.46 −1.45 −1.45 −1.45 −1.46 −1.46 −1.43 −1.51 −1.49 −1.48 −1.44 −1.48 −1.54
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along with mildly, moderately and severely emaciated and
obese anatomical rat models based on the deformable ROBY
model and anatomical parameters reported in the literature.
The major organs have almost the same masses and are
located in the same positions. There were small differences
in photon and electron SAFs and radionuclide-specific S-
values for most organs between the emaciated and obese
models and the normal model. The variations in SAFs for
the intestine irradiating some organs were found to be higher
in the obese models as a result of the changes in the position of
target regions. The anterior abdominal organs would receive a
higher cross-absorbed dose from the intestine whereas the
posterior abdominal organs would receive a lower cross-
absorbed dose because the increased volume of the epididy-
mal fat pad and visceral adipose tissues increases the separa-
tion of the intestine and posterior abdominal organs and shifts
the intestinal folds in the cephalic direction. The SAFs and
radionuclide S-values for the total body irradiating other re-
gions increased with decreasing bodymass. Overall, the effect
of obesity on dose calculations for internal irradiation is
insignificant in most conditions while emaciation could in-
crease the cross-absorbed dose of organs from surrounding
tissues, which might be an issue in small-animal internal
radiation dosimetry.
Acknowledgments This work was supported by the Swiss National
Science Foundation under grant SNSF 31003A-125246, the Geneva
Cancer League and the Indo-Swiss Joint Research Programme ISJRP
138866. The authors thank Dr. W. Paul Segars for providing the ROBY
computational rat model.
Conflicts of interest None.
References
1. Jönsson BA, Strand SE, Larsson BS. A quantitative autoradio-
graphic study of the heterogeneous activity distribution of different
indium-111-labeled radiopharmaceuticals in rat tissues. J Nucl
Med. 1992;33(10):1825–33.
2. Pasqualini R, Duatti A, Bellande E, Comazzi V, Brucato V,
Hoffschir D, et al. Bis(dithiocarbamato)nitrido technetium-99m
radiopharmaceuticals: a class of neutral myocardial imaging
agents. J Nucl Med. 1994;35(2):334–41.
3. Zaidi H, Xu XG. Computational anthropomorphic models of the
human anatomy: the path to realistic Monte Carlo modeling in
medical imaging. Annu Rev Biomed Eng. 2007;9(1):471–500.
4. Lee C, Lodwick D, Hasenauer D, Williams JL, Bolch WE.
Hybrid computational phantoms of the male and female new-
born patient: NURBS-based whole-body models. Phys Med
Biol. 2007;52(12):3309–33.
5. Hui TE, Fisher DR, Kuhn JA, Williams LE, Nourigat C, Badger
CC, et al. A mouse model for calculating cross-organ beta doses
from yttrium-90-labeled immunoconjugates. Cancer. 1994;73(3
Suppl):951–7.
6. Konijnenberg MW, Bijster M, Krenning EP, De Jong M. A stylized
computational model of the rat for organ dosimetry in support of
preclinical evaluations of peptide receptor radionuclide therapy
with 90Y, 111In, or 177Lu. J Nucl Med. 2004;45(7):1260–9.
7. Xie T, Zhang G, Li Y, Liu Q. Comparison of absorbed fractions of
electrons and photons using three kinds of computational phantoms
of rat. Appl Phys Lett. 2010;97(3):33702–4.
8. Flynn AA, Green AJ, Pedley RB, Boxer GM, Boden R, Begent RH.
Amouse model for calculating the absorbed beta-particle dose from
131I- and 90Y-labeled immunoconjugates, including a method for
dealing with heterogeneity in kidney and tumor. Radiat Res.
2001;156(1):28–35.
9. Miller WH, Hartmann-Siantar C, Fisher D, Descalle MA, Daly T,
Lehmann J, et al. Evaluation of beta-absorbed fractions in a mouse
model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu radionu-
clides. Cancer Biother Radiopharm. 2005;20(4):436–49.
10. Hindorf C, LjungbergM, Strand SE. Evaluation of parameters influenc-
ing S values in mouse dosimetry. J Nucl Med. 2004;45(11):1960–5.
11. Stabin MG, Peterson TE, Holburn GE, Emmons MA. Voxel-based
mouse and rat models for internal dose calculations. J Nucl Med.
2006;47(4):655–9.
12. Kolbert KS, Watson T, Matei C, Xu S, Koutcher JA, Sgouros G.
Murine S factors for liver, spleen, and kidney. J Nucl Med.
2003;44(5):784–91.
13. Bitar A, Lisbona A, Thedrez P, Sai Maurel C, Le Forestier D,
Barbet J, et al. A voxel-based mouse for internal dose calculations
using Monte Carlo simulations (MCNP). Phys Med Biol.
2007;52(4):1013–25.
14. Dogdas B, Stout D, Chatziioannou AF, Leahy RM. Digimouse: a
3D whole body mouse atlas from CT and cryosection data. Phys
Med Biol. 2007;52(3):577–87.
15. Mohammadi A, Kinase S. Monte Carlo simulations of photon
specific absorbed fractions in a mouse voxel pPhantom. Prog Nucl
Sci Technol. 2011;1:126–9.
16. Zhang X, Xie X, Cheng J, Ning J, Yuan Y, Pan J, et al. Organ dose
conversion coefficients based on a voxel mouse model andMCNP code
for external photon irradiation. Radiat Prot Dosim. 2012;148(1):9–19.
17. Peixoto PH, Vieira JW, Yoriyaz H, Lima FR. Photon and electron
absorbed fractions calculated from a new tomographic rat model.
Phys Med Biol. 2008;53(19):5343–55.
18. Wu L, Zhang G, Luo Q, Liu Q. An image-based rat model for Monte
Carlo organ dose calculations. Med Phys. 2008;35(8):3759–64.
19. Xie T, Liu Q, Zaidi H. Evaluation of S-values and dose distributions
for 90Y, 131I, 166Ho, and 188Re in seven lobes of the rat liver.
Med Phys. 2012;39(3):1462–72.
20. Segars WP, Tsui BM, Frey EC, Johnson GA, Berr SS. Development
of a 4-D digital mouse phantom for molecular imaging research.
Mol Imaging Biol. 2004;6(3):149–59.
21. Keenan MA, Stabin MG, Segars WP, Fernald MJ. RADAR realistic
animal model series for dose assessment. J Nucl Med.
2010;51(3):471–6.
22. Xie T, Zaidi H. Monte Carlo-based evaluation of S-values in mouse
models for positron-emitting radionuclides. Phys Med Biol.
2013;58(1):169–82.
23. Coop KL, Sharp JG, Osborne JW, Zimmerman GR. An animal model
for the study of small-bowel tumors. Cancer Res. 1974;34(6):1487–94.
24. Nagler R. Extended-term effects of head and neck irradiation in a
rodent. Eur J Cancer. 2001;37(15):1938–45.
25. Thomas R, Thomas RL, Wright S. Retention of cesium-137 and
strontium-90 administered in lethal doses to rats. Am Ind Hyg
Assoc J. 1968;29(6):593–600.
26. Stone HB, Moulder JE, Coleman CN, Ang KK, Anscher MS,
Barcellos-Hoff MH, et al. Models for evaluating agents intended
for the prophylaxis, mitigation and treatment of radiation injuries.
Report of an NCI workshop, December 3-4, 2003. Radiat Res.
2004;162(6):711–28.
27. Larsson E, Ljungberg M, Mårtensson L, Nilsson R, Tennvall J,
Strand SE, et al. Use of Monte Carlo simulations with a realistic rat
1758 Eur J Nucl Med Mol Imaging (2013) 40:1748–1759
phantom for examining the correlation between hematopoietic sys-
tem response and red marrow absorbed dose in Brown Norway rats
undergoing radionuclide therapy with 177Lu- and 90Y-BR96
mAbs. Med Phys. 2012;39(7):4434–43.
28. Kennedy G. The role of depot fat in the hypothalamic control
of food intake in the rat. Proc R Soc Lond B Biol Sci.
1953;140(901):578–92.
29. Pass D, Freeth G. The rat. ANZCCART News. 1993;6(4):1–4.
30. Donaldson HH. The rat: data and reference tables for the albino rat
and the Norway rat. New Delhi: Nabu Press; 1915.
31. Bardia A, Holtan SG, Slezak JM, Thompson WG. Diagnosis of
obesity by primary care physicians and impact on obesity manage-
ment. Mayo Clin Proc. 2007;82:927–32.
32. Kostanski M, Gullone E. Adolescent body image dissatis-
faction: relationships with self-esteem, anxiety, and depres-
sion controlling for body mass. J Child Psychol Psychiatry.
1998;39(2):255–62.
33. Hashimoto PH, Goami Y, Yoneda K, Mori K, Shioyama M,
Hasegawa E, et al. Fine structure of rat liver, adrenal, testis and
seminal vesicle in experimental emaciation. J Electron Microsc.
1998;47(3):251–62.
34. Ochi M, Yoshioka H, Sawada T, Kusunoki T, Hattori T. New
adipocyte formation in mice during refeeding after long-term dep-
rivation. Am J Physiol. 1991;260(3):R468–74.
35. Reed LL, Anderson WE, Mendel LB. Factors Influencing the
distribution and character of adipose tissue in the rat. J Biol
Chem. 1932;96(2):313–23.
36. Jeanrenaud B, Renold AE. Studies on rat adipose tissue in vitro. J
Biol Chem. 1960;235(8):2217–23.
37. Pelowitz DB. MCNPX user’s manual version 2.5.0. Los Alamos,
NM: Los Alamos National Laboratory; 2005. LA-CP-05-0369.
38. Goldstone KE. Tissue substitutes in radiation dosimetry and mea-
surement. ICRU Report 44. Vol 41. International Commission on
Radiation Units and Measurements; 1990.
39. Valentin J. Basic anatomical and physiological data for use in
radiological protection: reference values – ICRP publication 89.
Ann ICRP. 2002;32(3-4):5–265.
40. Xie T, Han D, Liu Y, Sun J, Liu Q. Skeletal dosimetry in a voxel-
based rat phantom for internal exposures to photons and electrons.
Med Phys. 2010;37(5):2167–78.
41. Myers R. The biological application of small animal PET imaging.
Nucl Med Biol. 2001;28(5):585–93.
42. Shimoji K, Ravasi L, Schmidt K, Soto-Montenegro ML, Esaki T,
Seidel J, et al. Measurement of cerebral glucose metabolic rates in
the anesthetized rat by dynamic scanning with 18F-FDG, the
ATLAS small animal PET scanner, and arterial blood sampling. J
Nucl Med. 2004;45(4):665–72.
43. Herrero P, Kim J, Sharp TL, Engelbach JA, Lewis JS, Gropler RJ, et al.
Assessment of myocardial blood flow using 15O-water and 1-11C-
acetate in rats with small-animal PET. J NuclMed. 2006;47(3):477–85.
44. Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet
no. 21: a generalized schema for radiopharmaceutical dosimetry –
standardization of nomenclature. J Nucl Med. 2009;50(3):477–84.
45. SnyderWS, FordMR,Warner GG,Watson SB.MIRDpamphlet no. 11:
‘S’, absorbed dose per unit cumulated activity for selected radionuclides
and organs. New York: The Society of Nuclear Medicine; 1975.
46. Health Physics Society. Radionuclide decay data. McLean, VA:
Health Physics Society. http://hps.org/publicinformation/
radardecaydata.cfm. Accessed 21 Jun 2013.
47. Bardies M, Chatal JF. Absorbed doses for internal radiotherapy
from 22 beta-emitting radionuclides: beta dosimetry of small
spheres. Phys Med Biol. 1994;39(6):961–81.
Eur J Nucl Med Mol Imaging (2013) 40:1748–1759 1759
